港股異動丨DYNAM JAPAN(06889.HK)跌超6% 預警稱截至6月止季度不會錄得溢利
格隆匯5月28日丨DYNAM JAPAN(06889.HK)跌超6%,報7.32港元,總市值56億港元。日本彈珠機企業DYNAM JAPAN午間發盈警,預期截至6月底止季度,將不會錄得溢利。受新冠肺炎疫情影響,日本全國進入緊急狀態,DYNAM JAPAN披露指,集團於4月底止5月初期間,關閉旗下全部日式彈珠機遊戲館,於4月底,已暫停428間日式彈珠機遊戲館營業,佔集團總數的96%;與疫情前相比,遊戲機使用率跌至約53%,經營收益下跌65%。於5月,集團經營遊戲館的日數為正常水平的53%,遊戲機使用率下跌至正常水平約一半,經營收益較去年同期下跌約70%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.